Infectious Disease Advisor Contributing Writer

Researchers examined the efficacy and safety of the respiratory syncytial virus (RSV) prefusion F protein-based vaccine among older adults over 2 RSV seasons.

The median incubation period for coronavirus disease 2019 (COVID-19) is approximately 5 days, according to study results published in medRxiv.